Latest News and Press Releases
Want to stay updated on the latest news?
-
Luton, Bedfordshire, United Kingdom, Aug. 24, 2024 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed...
-
New York, May 15, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Global Cancer Biomarkers Market was valued at USD 15.68 billion in 2023 and is anticipated to generate an estimated revenue of USD...
-
Wilmington, Delaware, United States, April 26, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, tThe global cancer biomarkers market size stood at USD 12.6 Bn in 2021. The market...
-
Pune, India, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The global cancer biomarkers market size was valued at USD 18.94 billion in 2018. The market in 2018 is projected to grow from USD 18.94 billion to USD...
-
Portland, OR, Feb. 01, 2023 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Carrier Screening Market size was estimated at $1.8 billion in 2021...
-
WASHINGTON, May 29, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Cancer Biomarkers Market finds that the rise in prevalence of various types of cancers such as...
-
Brussels, Belgium, May 17, 2022 (GLOBE NEWSWIRE) -- Description: Cancer biomarkers are biological molecules that indicate the presence of cancer in a patient. They are produced either by the...
-
Delhi, March 15, 2022 (GLOBE NEWSWIRE) -- Global Breast Cancer Antibodies Biomarkers & Clinical Trials Insight 2028 Report Highlights: Global Breast Cancer Antibodies Market Opportunity:...
-
Delhi, March 11, 2022 (GLOBE NEWSWIRE) -- Global Breast Cancer Antibodies Biomarkers & Clinical Trials Insight 2028 Report Highlights: Global Breast Cancer Antibodies Market Opportunity:...
-
Delhi, March 03, 2022 (GLOBE NEWSWIRE) -- Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028 Report Highlights: Global Immune Checkpoint Inhibitors Market...